Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Response to Naltrexone (NTX): Next Steps in Managing Alcoholism
NCT00115037Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2003
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naltrexone in alcohol dependence (6 arms), sponsored by University of Pennsylvania. Primary endpoints: Count of Responders and Non-responders in Phase 1 at 8 weeks and Percentage of Heavy Drinking Days at 16 weeks. Started Sep 2003; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00115037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115037.